CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Maintains Focus on Advancing Clinical Development Program for Lead Drug Candidate, Berubicin

Nov 14, 2022

  • In June 2020, CNS’ lead drug candidate, Berubicin, received Orphan Drug designation from the FDA. In June 2021, it received Fast Track designation following positive results from an extensive clinical study that saw 44% of the patients post a clinical response, with one Durable Complete Response
  • With GBM having a survival rate of only 6.8% and an average length of survival of only eight months, Berubicin is showing tremendous potential, and CNS is leading the charge to find a potential treatment option for the disease
  • CNS’ management is optimistic about its lead drug candidate and continues to explore the potential treatment of other conditions such as lymphomas, lung and breast cancers

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical stage biotechnology company, recognizes the growing problem of metastatic cancers of the brain and central nervous system. More importantly, it recognizes how few and largely ineffective current solutions are available, ultimately contributing to higher mortality rates and a poor quality of life for victims with such conditions.

This understanding led to the introduction of Berubicin, the company’s lead drug candidate aimed at treating Glioblastoma Multiforme (“GBM”), with the potential to also deal with other central nervous…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

More News

Why Trump-Xi summit must put Korean peninsula back on the agenda
Sep 21, 2026
Why Trump-Xi summit must put Korean peninsula back on the agenda

The September 24 summit between President Xi Jinping and US President Donald Trump is no ordinary engagement. Their May summit took place in Beijing and largely centred on economic issues. This one will be on Trump’s home turf and is expected to put strategic questions on the table. Will the Korean peninsula and North Korea’s nuclear programme again be pushed to the margins? In Beijing, both sides focused on their immediate national interests, such as trade, semiconductors, rare earths and...

An Unused and Divisive Philippine Nuclear Plant Awaits Its Fate
Sep 21, 2026
An Unused and Divisive Philippine Nuclear Plant Awaits Its Fate

The Filipino government is exploring nuclear power options to guard against global energy shocks. One proposal is to switch on a plant in Bataan that has been mothballed for 40 years.

Why Indonesians Feel Increasingly Bitter Today
Sep 21, 2026
Why Indonesians Feel Increasingly Bitter Today

Indonesia’s rising public anger reflects deeper structural pressures – from elite impunity to digital manipulation – eroding trust in democratic institutions.

U.N. General Assembly to Confront Familiar Crises, New Conflicts and A.I.
Sep 21, 2026
U.N. General Assembly to Confront Familiar Crises, New Conflicts and A.I.

The United Nations is also searching for a replacement for António Guterres, who has served two terms as the secretary general and is stepping down.

Sisters of Pakistan’s Imran Khan arrested in Lahore, jailed ex-PM’s party says
Sep 21, 2026
Sisters of Pakistan’s Imran Khan arrested in Lahore, jailed ex-PM’s party says

Former Pakistan prime minister Imran Khan’s party said on Monday that his three sisters had been arrested ahead of ‌a protest ⁠march planned for September 27. “Punjab police have raided Aleema Khan’s home and have abducted Imran Khan’s other two sisters, his nephews and their children,” Zulfi Bukhari, a spokesman for Khan’s Pakistan Tehreek-e-Insaf (PTI) party, said on social media. “Khan’s sisters and their children were taken into custody but the children were released,” PTI’s information...

At 92, the Bard of Bollywood Is Still Writing About Love
Sep 21, 2026
At 92, the Bard of Bollywood Is Still Writing About Love

The poet and lyricist Gulzar has profoundly shaped the idea of tender romance in India through his verse and songs in more than 150 musicals.

One Issue That Could Upend Fragile U.S.-China Ties: Taiwan Arms
Sep 21, 2026
One Issue That Could Upend Fragile U.S.-China Ties: Taiwan Arms

As Beijing presses President Trump to freeze a proposed $14 billion weapons sale to the island, Taiwan is trying to show that its security is in U.S. interests.

Why Bangladesh Skipped the Delhi BRICS Summit
Sep 21, 2026
Why Bangladesh Skipped the Delhi BRICS Summit

What the decision means (and doesn't mean) for Bangladesh-India relations.

Busting the Myths of the US Military’s Presence in Hawai‘i
Sep 21, 2026
Busting the Myths of the US Military’s Presence in Hawai‘i

As land leases come up for renewal, a new report reveals the facts about the U.S. Armed Forces’ impacts in the Pacific Islands.

China Promised to Buy More U.S. Farm Goods. It Hasn’t Happened.
Sep 21, 2026
China Promised to Buy More U.S. Farm Goods. It Hasn’t Happened.

Soybeans are the notable exception, revealing Beijing’s selective approach to fulfilling trade commitments ahead of the summit between President Trump and Xi Jinping.

Why Egypt Is Looking Beyond Its Trade Deficit With China
Sep 21, 2026
Why Egypt Is Looking Beyond Its Trade Deficit With China

Trade access matters, but investment can also change what Africa produces, where it produces it, and which markets it can serve.

Ahead of Trump-Xi Summit, North Korea Launches More Missiles
Sep 21, 2026
Ahead of Trump-Xi Summit, North Korea Launches More Missiles

On September 20, North Korea fired two short-range ballistic missiles, its second launch in a little over a week.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Indo Inquirer

Indo Inquirer is the leading online news network in Indonesia, providing daily breaking news with in-depth news coverage and the best photojournalism. We deliver compelling and diverse engaging stories around the world.

Newsletter